71.20.B - Other technical testing and analysis
68.20.Z - Rental and operating of own or leased real estate
71.20.A - Food quality testing and analysis
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
77.40.Z - Leasing of intellectual property and similar products, except copyrighted works
82.99.Z - Other business support service activities not elsewhere classified
86.10.Z - Hospital activities
86.90.E - Other human health activities notelsewhere classified
2018 | 2019 | 2020 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -15,5 | -73,6 | 115,4 | 256,8 |
EBITDA | -14,8 | -68,5 | 116,3 | 269,9 |
Short time liabilities | 122,9 | 253,7 | 231,2 | -8,9 |
Equity capital | 35,9 | -37,7 | 54,8 | 245,3 |
Operating profit (EBIT) | -14,8 | -69,6 | 116,2 | 266,9 |
Assets | 158,8 | 216 | 286 | 32,4 |
Net profit (loss) | -15,5 | -73,6 | 105,5 | 243,4 |
Cash | 0 | 0 | 14,8 | -∞ |
Net income from sale | 484,8 | 535,8 | 744,3 | 38,9 |
Liabilities and provisions for liabilities | 122,9 | 253,7 | 231,2 | -8,9 |
Working assets | 158,8 | 210,8 | 280,9 | 33,2 |
Depreciation | 0 | 1,2 | 0,1 | -91,8 |
% | % | % | p.p. | |
Profitability of capital | -43,3 | 195,1 | 192,6 | -2,5 |
Equity capital to total assets | 22,6 | -17,5 | 19,2 | 36,7 |
Gross profit margin | -3,2 | -13,7 | 15,5 | 29,2 |
EBITDA Margin | -3,1 | -12,8 | 15,6 | 28,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 93 | 173 | 113 | -60 |
Current financial liquidity indicator | 1.2916977405548096 | 0.8311267495155334 | 1.2147306203842163 | 0,4 |
Net dept to EBITDA | -0.7097625732421875 | -0.7901548147201538 | 0.1325109302997589 | 0,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane